AERIE PHARMACEUTICALS INC Insider Trading for February 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AERIE PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AERIE PHARMACEUTICALS INC for February 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Option Exercise | A | 44.25 | 43,019 | 1,903,591 | 43,019 | |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Payment of Exercise | F | 44.55 | 845 | 37,645 | 402,135 | 403 K to 402.1 K (-0.21 %) |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Payment of Exercise | F | 44.55 | 932 | 41,521 | 402,980 | 403.9 K to 403 K (-0.23 %) |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Grant | A | 0.00 | 4,780 | 0 | 403,912 | 399.1 K to 403.9 K (+1.20 %) |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Option Exercise | A | 44.25 | 79,418 | 3,514,247 | 79,418 | |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Payment of Exercise | F | 44.55 | 1,116 | 49,718 | 34,042 | 35.2 K to 34 K (-3.17 %) |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Payment of Exercise | F | 44.55 | 1,116 | 49,718 | 35,158 | 36.3 K to 35.2 K (-3.08 %) |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Grant | A | 0.00 | 8,824 | 0 | 36,274 | 27.5 K to 36.3 K (+32.15 %) |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Option Exercise | A | 44.25 | 39,709 | 1,757,123 | 39,709 | |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Payment of Exercise | F | 44.55 | 593 | 26,418 | 185,061 | 185.7 K to 185.1 K (-0.32 %) |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Payment of Exercise | F | 44.55 | 741 | 33,012 | 185,654 | 186.4 K to 185.7 K (-0.40 %) |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Grant | A | 0.00 | 4,412 | 0 | 186,395 | 182 K to 186.4 K (+2.42 %) |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | A | 44.25 | 155,528 | 6,882,114 | 155,528 | |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 44.55 | 1,518 | 67,627 | 87,065 | 88.6 K to 87.1 K (-1.71 %) |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 44.55 | 1,716 | 76,448 | 88,583 | 90.3 K to 88.6 K (-1.90 %) |
| Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 17,281 | 0 | 90,299 | 73 K to 90.3 K (+23.67 %) |
| Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Option Exercise | M | 3.15 | 28,000 | 88,200 | 0 | |
| Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Option Exercise | M | 17.55 | 13,500 | 236,925 | 0 | |
| Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Option Exercise | M | 32.30 | 10,000 | 323,000 | 0 | |
| Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Option Exercise | M | 19.50 | 6,667 | 130,007 | 3,333 | |
| Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Sell | S | 46.81 | 20,796 | 973,438 | 3,400 | 24.2 K to 3.4 K (-85.95 %) |
| Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Sell | S | 46.46 | 20,795 | 966,059 | 24,196 | 45 K to 24.2 K (-46.22 %) |
| Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Payment of Exercise | F | 46.95 | 1,879 | 88,219 | 44,991 | 46.9 K to 45 K (-4.01 %) |
| Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Buy | M | 3.15 | 28,000 | 88,200 | 46,870 | 18.9 K to 46.9 K (+148.38 %) |
| Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Payment of Exercise | F | 46.95 | 5,047 | 236,957 | 18,870 | 23.9 K to 18.9 K (-21.10 %) |
| Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Buy | M | 17.55 | 13,500 | 236,925 | 23,917 | 10.4 K to 23.9 K (+129.60 %) |
| Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Payment of Exercise | F | 46.95 | 6,880 | 323,016 | 10,417 | 17.3 K to 10.4 K (-39.78 %) |
| Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Buy | M | 32.30 | 10,000 | 323,000 | 17,297 | 7.3 K to 17.3 K (+137.04 %) |
| Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Payment of Exercise | F | 46.95 | 2,770 | 130,052 | 7,297 | 10.1 K to 7.3 K (-27.52 %) |
| Feb 16 2017 | AERI | AERIE PHARMACEUTIC ... | DUYK GEOFFREY M | Director | Buy | M | 19.50 | 6,667 | 130,007 | 10,067 | 3.4 K to 10.1 K (+196.09 %) |